Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study

Diabetes Technology and Therapeutics

Volumn 18, Issue 12, 2016, Pages 772-783

  Sharifi, Amin ^a   De Bock, Martin I ^b   Jayawardene, Dilshani ^a   Loh, Margaret M ^a   Horsburgh, Jodie C ^a   Berthold, Carolyn L ^b   Paramalingam, Nirubasini ^b   Bach, Leon A ^c   Colman, Peter G ^d   Davis, Elizabeth A ^b   Grosman, Benyamin ^e   Hendrieckx, Christel ^f,g   Jenkins, Alicia J ^a,h,i   Kumareswaran, Kavita ^c   Kurtz, Natalie ^e   Kyoong, Andrew ^a   MacIsaac, Richard J ^a,h   Speight, Jane ^f,g,j   Trawley, Steven ^f,g   Ward, Glenn M ^a,h   Roy, Anirban ^e   Jones, Timothy W ^b   O'Neal, David N ^a,h   more..

^a ST VINCENT S HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e MEDTRONIC INC   (United States)

^f THE AUSTRALIAN CENTRE FOR BEHAVIOURAL RESEARCH IN DIABETES   (Australia)

^g DEAKIN UNIVERSITY   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j AHP Research   (United Kingdom)

more..

Author keywords

Artificial pancreas; Closed loop; Continuous subcutaneous insulin infusion; Insulin pumps; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ANDROID BASED HYBRID CLOSED LOOP SYSTEM; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; NIGHT; OPEN STUDY; PATIENT SATISFACTION; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSOR AUGMENTED PUMP WITH LOW GLUCOSE SUSPEND FUNCTION; SLEEP QUALITY; TIME; AMBULATORY MONITORING; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; MICROCOMPUTER; MIDDLE AGED; SLEEP;

ADOLESCENT; ADULT; BLOOD GLUCOSE; COGNITION; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MICROCOMPUTERS; MIDDLE AGED; MONITORING, AMBULATORY; PROSPECTIVE STUDIES; SLEEP;

EID: 85006983291     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0288     Document Type: Article

References (31)

1. Thabit H, Tauschmann M, Allen JM, et al.: Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015; 373:2129-2140.
2. Ruan Y, Thabit H, Leelarathna L, et al.: Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes. Diabetes Care 2016; 39:830-832.
3. Hovorka R, Allen JM, Elleri D, et al.: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomized crossover trial. Lancet 2010; 375:743-751.
4. Kovatchev BP, Renard E, Cobelli C, et al.: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36: 1851-1858.
5. Russell SJ, El-Khatib FH, Sinha M, et al.: Outpatient gly-cemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313-325.
6. Nimri R, Muller I, Atlas E, et al.: MD-logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014;37:3025-3032.
7. Thabit H, Lubina-Solomon A, Stadler M, et al.: Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomized crossover study. Lancet Diabetes Endocrinol 2014;2:701-709.
8. Leelarathna L, Dellweg S, Mader JK, et al.: Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care 2014;37:1931-1937.
9. Hovorka R, Elleri D, Thabit H, et al.: Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014; 37:1204-1211.
10. Bergenstal RM, Klonoff DC, Garg SK, et al.: Threshold-based insulin-pump interruption for reduction of hypogly-cemia. N Engl J Med 2013;369:224-232.
11. Ly TT, Nicholas JA, Retterath A, et al.: Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypogly-cemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-1247.
12. Ly TT, Roy A, Grosman B, et al.: Day and night closed-loop control using the integrated medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp. Diabetes Care 2015;38:1205-1211.
13. De Bock MI, Roy A, Cooper MN, et al.: Feasibility of outpatient 24-hour closed-loop insulin delivery. Diabetes Care 2015;38:e186-e187.
14. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type I diabetes. N Engl J Med 2008 359:1464-1476
15. Jenkins AJ, Krishnamurthy B, Best JD, et al.: Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a random-ized controlled trial. Diabetes Care 2010;33:1242-1248.
16. Barnard KD, Wysocki T, Allen JM, et al.: Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care 2014;2:e000025.
17. Januszewski AS, Karschimkus C, Davis KE, et al.: Plasma 1, 5 anhydroglucitol levels, a measure of short-term glycae-mia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Res Clin Pract 2012;95:e17-e19.
18. Albano JD, Ekins RP, Maritz G, Turner RC: A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh). 1972; 70:487-509.
19. Bradley C: The diabetes treatment satisfaction questionnaire: DTSQ. In: Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers, 1994, pp. 111-132.
20. Bradley C: Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 1999;22:530-532.
21. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1997;20:760-766.
22. Gonder-Frederick LA, Schmidt KM, Vajda KA, et al. Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes. Diabetes Care 2011;34:801-806.
23. Gonder-Frederick L, Nyer M, Shepard JA, et al.: Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manag (Lond) 2011;1:627-639.
24. Hoddes E, Zarcone V, Dement W: Development and use of Stanford Sleepiness Scale (SSS). Psychophysiology 1972; 9:150.
25. Falleti MG, Maruff P, Collie A, et al.: Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.JClin Exp Neuropsychol 2006;28: 1095-1112.
26. Buysse DJ, Reynolds CF, 3rd, Monk TH, et al.: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
27. Kovatchev B, Cobelli C, Renard E, et al.: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
28. Haidar A, Legault L, Messier V, et al.: Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomized controlled crossover trial. Lancet Diabetes En-docrinol 2015;3:17-26.
29. Phillip M, Battelino T, Atlas E, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
30. Breton M, Farret A, Bruttomesso D, et al.: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
31. Bloch CA, Clemons P, Sperling MA: Puberty decreases insulin sensitivity. J Pediatr 1987;110:481-487.